US Drug Recall Register

Is Chloride recalled?

Yes — there is an active recall. 326 ongoing FDA recalls mention Chloride (1,994 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chloride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Benzalkonium Chloride 0.013% Solution

Reason Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0055-2022
Class II · Moderate risk Terminated

Magnesium Chloride

Reason Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0029-2022
Class II · Moderate risk Terminated

Calcium Chloride

Reason Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0028-2022
Class II · Moderate risk Terminated

Fexofenadine Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications

The Harvard Drug Group NDC 0904-6979-40 D-0289-2022
Class II · Moderate risk Terminated

Succinylcholine Chloride 100 mg/5 mL

Reason Lack of sterility assurance

BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy D-0702-2021
Class II · Moderate risk Terminated

Cyclobenzaprine Hydrochloride Tablets

Reason CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.

Teva Pharmaceuticals USA NDC 57237-266-01 D-0776-2021
Class II · Moderate risk Terminated

Cyclobenzaprine Hydrochloride Tablets

Reason CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.

Teva Pharmaceuticals USA NDC 70199-014-01 D-0775-2021
Class II · Moderate risk Terminated

Cyclobenzaprine Hydrochloride Tablets

Reason CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.

Teva Pharmaceuticals USA NDC 0591-3330-01 D-0774-2021
Class II · Moderate risk Terminated

Cimetidine Hydrochloride Oral Solution 300 mg/5 mL

Reason Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-0649-08 D-0722-2021
Class II · Moderate risk Terminated

GoodSense Aller.Ease

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0113-0571-30 D-0357-2022
Class II · Moderate risk Terminated

CVS Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 69842-698-39 D-0356-2022
Class II · Moderate risk Terminated

Kirkland Aller-Fex

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 63981-571-48 D-0355-2022
Class II · Moderate risk Terminated

amazon basic+care

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 72288-425-78 D-0354-2022
Class II · Moderate risk Terminated

Wal-Fex Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0363-0903-62 D-0353-2022
Class II · Moderate risk Terminated

Wal-Fex Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0363-0600-13 D-0352-2022
Class II · Moderate risk Terminated

up&up allergy relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 11673-571-22 D-0351-2022
Class II · Moderate risk Terminated

TopCare Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 36800-319-13 D-0350-2022
Class II · Moderate risk Terminated

TopCare Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 36800-954-53 D-0349-2022
Class II · Moderate risk Terminated

Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 11822-0571-2 D-0348-2022
Class II · Moderate risk Terminated

Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 11822-0425-0 D-0347-2022
Class II · Moderate risk Terminated

Perrigo Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 45802-425-78 D-0346-2022
Class II · Moderate risk Terminated

Perrigo Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 45802-571-78 D-0345-2022